JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.54B |
| 2 |
NVIDIA
NVDA
|
+$5.22B |
| 3 |
Apple
AAPL
|
+$3.2B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.51B |
| 5 |
Walt Disney
DIS
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.6B |
| 2 |
UnitedHealth
UNH
|
+$2.41B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.15B |
| 4 |
Linde
LIN
|
+$1.93B |
| 5 |
Union Pacific
UNP
|
+$1.87B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.6% |
| 2 | Financials | 9.92% |
| 3 | Consumer Discretionary | 9.63% |
| 4 | Communication Services | 7.24% |
| 5 | Healthcare | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Delcath Systems
DCTH
$534M
| $2.29M | ﹤0.01% |
168,245
+117,118
| +229% | +$1.63M |
|
|
SVC
3652
Service Properties Trust
SVC
$1.09B
| $2.28M | ﹤0.01% |
191,051
+25,051
| +15% | +$271K |
|
|
EDN
3653
Edenor
EDN
$1.09B
| $2.27M | ﹤0.01% |
85,814
-2,950
| -3% | -$91.8K |
|
|
PRA
3654
DELISTED
ProAssurance
PRA
| $2.27M | ﹤0.01% |
99,509
-328,769
| -77% | -$7.59M |
|
3655
Pliant Therapeutics
PLRX
$65M
| $2.27M | ﹤0.01% |
1,958,433
+1,477,336
| +307% | +$2.09M |
|
3656
CALL
New Fortress Energy
NFE
$98M
| $2.27M | ﹤0.01% |
+683,800
| New | +$2.97M |
|
3657
PUT
Abercrombie & Fitch
ANF
$4.91B
| $2.27M | ﹤0.01% |
27,400
+400
| +1% | +$30.3K |
|
|
PMTRU
3658
Perimeter Acquisition Corp I Unit
PMTRU
$195M
| $2.27M | ﹤0.01% |
+216,680
| New | +$2.23M |
|
3659
Fidelity Momentum Factor ETF
FDMO
$950M
| $2.26M | ﹤0.01% |
29,822
+13,035
| +78% | +$897K |
|
3660
PureCycle Technologies
PCT
$1.38B
| $2.26M | ﹤0.01% |
164,762
+7,798
| +5% | +$69K |
|
3661
CALL
WillScot Mobile Mini Holdings
WSC
$4.67B
| $2.25M | ﹤0.01% |
82,000
+80,600
| +5,757% | +$2.15M |
|
3662
WisdomTree US SmallCap Earnings Fund
EES
$726M
| $2.25M | ﹤0.01% |
44,080
-8,159
| -16% | -$394K |
|
3663
Plug Power
PLUG
$2.89B
| $2.24M | ﹤0.01% |
1,504,744
+299,876
| +25% | +$299K |
|
|
DX
3664
Dynex Capital
DX
$3.18B
| $2.24M | ﹤0.01% |
183,247
+129,601
| +242% | +$1.57M |
|
|
BBOT
3665
BridgeBio Oncology
BBOT
$703M
| $2.24M | ﹤0.01% |
210,125
+57,909
| +38% | +$626K |
|
3666
Tidewater
TDW
$4.06B
| $2.24M | ﹤0.01% |
48,511
-11,233
| -19% | -$455K |
|
3667
Rentokil
RTO
$12.3B
| $2.24M | ﹤0.01% |
93,165
+89,649
| +2,550% | +$2.08M |
|
3668
Vir Biotechnology
VIR
$1.48B
| $2.23M | ﹤0.01% |
443,375
+4,069
| +0.9% | +$21.8K |
|
3669
RE/MAX Holdings
RMAX
$230M
| $2.23M | ﹤0.01% |
272,785
+71,301
| +35% | +$553K |
|
3670
Allot
ALLT
$372M
| $2.23M | ﹤0.01% |
+260,263
| New | +$1.87M |
|
3671
Clarivate
CLVT
$1.18B
| $2.22M | ﹤0.01% |
517,074
+19,507
| +4% | +$78.6K |
|
3672
Capital City Bank Group
CCBG
$894M
| $2.22M | ﹤0.01% |
56,338
-17,558
| -24% | -$647K |
|
|
AGS
3673
DELISTED
PlayAGS
AGS
| $2.21M | ﹤0.01% |
177,332
-100,531
| -36% | -$1.23M |
|
3674
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.74B
| $2.21M | ﹤0.01% |
13,716
-986
| -7% | -$157K |
|
3675
Leggett & Platt
LEG
$1.31B
| $2.21M | ﹤0.01% |
247,826
-283,382
| -53% | -$2.44M |
|
Similar funds
JP Morgan Chase's Q2 2025 Portfolio in Review
As of Q2 2025, JP Morgan Chase held 7,888 positions worth $1.53T, up 12% from $1.37T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
JP Morgan Chase's Q2 2025 filing shows 634 new, 2,516 increased, 3,216 reduced and 855 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.6B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M.
- JP Morgan Chase added most to Microsoft in Q2 2025, an estimated $6.54B increase.
- JP Morgan Chase's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.6B.
- JP Morgan Chase fully exited Discover Financial Services in Q2 2025, selling an estimated $370M.
- JP Morgan Chase's ten largest holdings make up 25% of its $1.53T portfolio in Q2 2025.
- JP Morgan Chase opened 634 new positions and closed 855 in Q2 2025.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $1.53T.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.